NCT06757478View on ClinicalTrials.gov

A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Lymphoma Patient
All Listed Sponsors
lead

First Affiliated Hospital of Ningbo University

NETWORK

NCT06757478 - A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma | Biotech Hunter | Biotech Hunter